IL12 p40 형광 리포터 생쥐 시스템을 이용한 B16 F/T 항암 백신의 면역활성 연구

키워드

참고문헌 (18)

1. Adachi O, "Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18- mediated function", 9, pp.143~150 (1998)
2. Appleman LJ, "CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression", 164, pp.144~151 (2000)
3. Appleman LJ, "T cell anergy and costimulation", 192, pp.161~180 (2003)
4. Bendelac A, "The biology of NKT cells", 25, pp.297~336 (2007)
5. Colombo MP, "Interleukin-12 in anti-tumor immunity and immunotherapy", 13, pp.155~168 (2002)
6. Cui J, "Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors", 278, pp.1623~1626 (1997)
7. Fong L, "Dendritic cells in cancer immunotherapy", 18, pp.245~273 (2000)
8. Guermonprez P, "Antigen presentation and T cell stimulation by dendritic cells", 20, pp.621~667 (2002)
9. Im W, "Cytokine reporter mouse system for screening novel IL12", 23 p40-inducing compounds, 2005, pp.20, 288~296
10. Janeway CA, Jr, "Innate immune recognition", 20, pp.197~216 (2002)
11. Reinhardt RL, "Visualization of IL-12", 23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation, 2006, pp.177, 1618~1627
12. Ruttinger D, "Immunotherapy of lung cancer: an update", 29, pp.33~38 (2006)
13. Schuster M, "Cancer immunotherapy", 1, pp.138~147 (2006)
14. Schwartz RH, "T cell anergy", 21, pp.305~334 (2003)
15. Seong SY, "Hydrophobicity: an ancient damageassociated molecular pattern that initiates innate immune responses", 4, pp.469~478 (2004)
16. van Duin D, "Triggering TLR signaling in vaccination", 27, pp.49~55 (2006)
17. Wang RF, "T cell-mediated immune responses in melanoma: implications for immunotherapy", 43, pp.1~11 (2002)
18. Ward EM, "Interpreting cancer trends", 1076, pp.29~53 (2006)

관련 논문AI추천